(Q51014384)

27 March 2018

title

Naloxone lowers plasma-prolactin in man. (English)

1 reference

27 March 2018

author

Terrence F. Blaschke

series ordinal

3

1 reference

27 March 2018

author name string

P Rubin

series ordinal

1

1 reference

27 March 2018

S Swezey

series ordinal

2

1 reference

27 March 2018

language of work or name

English

0 references

publication date

1 June 1979

1 reference

27 March 2018

published in

The Lancet

1 reference

27 March 2018

volume

1

1 reference

27 March 2018

issue

8129

1 reference

27 March 2018

page(s)

1293

1 reference

27 March 2018

Relation of endogenous opioid peptides and morphine to neuroendocrine functions

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992248-7

7 January 2021

Prolactin secretion, a measurable central effect of opiate-receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992248-7

7 January 2021

Negative naloxone effects on serum-prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992248-7

7 January 2021

Risk factors for ischaemic heart-disease in normal men aged 40. Edinburgh-Stockholm Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992248-7

7 January 2021

A co-operative trial in the primary prevention of ischaemic heart disease using clofibrate. Report from the Committee of Principal Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992248-7

7 January 2021

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2879%2992248-7

7 January 2021

10.1016/S0140-6736(79)92248-7

Identifiers

DOI

1 reference

27 March 2018

1 reference

27 March 2018